Merck, a leading global pharmaceutical company that produces a range of medicines, vaccines, and animal healthcare products, ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the closing of the exclusive global ...

About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo.

“Merck本身就很有吸引力，而且它的产品组合特点也非常好，”Oakmark Funds的投资组合经理Nygren在接受CNBC采访时说道。他在第三季度买入了Merck的股票。

在当前医学领域，RCC约占所有肾癌病例的最大比例，并且在2020年，欧洲新诊断的RCC案例超过130,000。这意味着，WELIREG的推出不仅会改变患者的命运，也为Merck的肿瘤学研究开辟了一条充满希望的新道路。

Merck said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several ...

The weight-loss biotech Viking Therapeutics (NASDAQ: VKTX) saw its stock get absolutely slammed on Dec. 18, falling 18% as a ...

Merck's strong financial performance in oncology and vaccines drove a 9% sales increase earlier in Q1 of 2024. See why I rate ...

An FDA approval of Merck’s drug clesrovimab by June would give physicians another option for protecting newborns from ...

The company is scrapping two drugs aimed at targets called TIGIT and LAG-3, both of which were in the middle of Phase 3 ...

Merck announced a weight loss drug deal Wednesday with China-based Hansoh worth up to $2 billion for the pill code-named ...

根据许可协议，许可人将授予被许可人开发、生产及商业化临床前口服小分子 ...